10 Most-Advertised Brand-Name Drugs

AUGUST 27, 2015
Allison Gilchrist, Associate Editor

9.      Abilify ($107.9 million spent on advertising)

Bristol-Myers Squibb (BMS) and Otsuka collectively spent $107.9 million on advertising their schizophrenia and bipolar disorder treatment, Abilify, which accounted for 12.6% and 40% of BMS’s and Otsuka’s 2014 sales, respectively.
The FDA approved the first generic versions of Abilify (aripiprazole) in April 2015. Despite the loss of patent protection, 8.3 million total prescriptions were written for Abilify in the first half of 2015.

Abilify is ranked No. 2 on the top 10 list of best-selling brand-name drugs for 2015.